amphetamine has been researched along with Aphasia in 6 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Aphasia: A cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of aphasia.
Excerpt | Relevance | Reference |
---|---|---|
"Neuromodulation with pharmacological agents, including drugs of abuse such as amphetamine, when paired with behavioral experience, has been shown to positively modify outcomes in animal models of stroke." | 8.93 | Amphetamine and other pharmacological agents in human and animal studies of recovery from stroke. ( Johnson, M; Mehta, J; Smith, P; Walker-Batson, D, 2016) |
"Neuromodulation with pharmacological agents, including drugs of abuse such as amphetamine, when paired with behavioral experience, has been shown to positively modify outcomes in animal models of stroke." | 4.93 | Amphetamine and other pharmacological agents in human and animal studies of recovery from stroke. ( Johnson, M; Mehta, J; Smith, P; Walker-Batson, D, 2016) |
"Pharmacotherapy of aphasia had been discussed for the last twenty years with first bromocriptine and amphetamine and then serotoninergic, GABAergic and cholinergic agents." | 4.84 | Pharmacotherapy of aphasia: myth or reality? ( de Boissezon, X; de Boysson, C; Démonet, JF; Peran, P, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Walker-Batson, D | 1 |
Mehta, J | 1 |
Smith, P | 1 |
Johnson, M | 1 |
FISH, CH | 1 |
BOWLING, E | 1 |
Bakheit, AM | 1 |
de Boissezon, X | 1 |
Peran, P | 1 |
de Boysson, C | 1 |
Démonet, JF | 1 |
Chynn, KY | 1 |
Teuber, HL | 1 |
3 reviews available for amphetamine and Aphasia
Article | Year |
---|---|
Amphetamine and other pharmacological agents in human and animal studies of recovery from stroke.
Topics: Amphetamine; Animals; Aphasia; Humans; Neuroprotective Agents; Recovery of Function; Stroke | 2016 |
Drug treatment of poststroke aphasia.
Topics: Amphetamine; Aphasia; Bromocriptine; Humans; Stroke | 2004 |
Pharmacotherapy of aphasia: myth or reality?
Topics: Amphetamine; Aphasia; Bromocriptine; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; | 2007 |
3 other studies available for amphetamine and Aphasia
Article | Year |
---|---|
Effect of amphetamines on speech defects in the mentally retarded.
Topics: Amphetamine; Aphasia; Cleft Palate; Deafness; Dextroamphetamine; Double-Blind Method; Humans; Intell | 1962 |
Acute subarachnoid hemorrhage.
Topics: Acute Disease; Administration, Oral; Adult; Amphetamine; Aphasia; Cannabis; Carotid Arteries; Cocain | 1975 |
Functional recovery after lesions of the nervous system. II. Recovery of function after lesions of the central nervous system: history and prospects.
Topics: Age Factors; Amphetamine; Anesthesia, General; Animals; Aphasia; Brain Injuries; Brain Mapping; Cats | 1974 |